COMPLEMENT INHIBITOR ECULIZUMAB IN ATYPICAL HEMOLYTIC-UREMIC SYNDROME: SINGLE CENTER CASE SERIES

Autor:	Monika Vitkauskaitė, Artūras Vinikovas, Marius Miglinas, Laurynas Rimševičius, Agnė Čerkauskaitė, Ernesta Mačionienė, Eglė Ašakienė
Rok vydání:	2021
DOI:	10.22541/au.163338587.71549695/v1
Popis:	Our case series showed that eculizumab is efficacious and safe in treating atypical hemolytic-uremic syndrome, as well as it has positive effects on quality of life. Further extensive studies are required to develop unified treatment guidelines.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0be149b744b9ada3273ba2c6c225079c https://doi.org/10.22541/au.163338587.71549695/v1 Zobrazit plný text záznamu